Thiotepa Antineoplastic and Immunosuppressive Antibiotics inhibitor

Cat.No.S1775

Thiotepa (Thioplex, Tiofosyl, Tiofosfamid, Triethylenethiophosphoramide) is an alkylating agent used to treat cancer.
Jump to

Quality Control

Batch: Purity: 99.91%
99.91

Solubility

In vitro
Batch:

DMSO : 38 mg/mL (200.82 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 13 mg/mL

Water : 3 mg/mL

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 189.22 Formula

C6H12N3PS

Storage (From the date of receipt)
CAS No. 52-24-4 Download SDF Storage of Stock Solutions

Synonyms Tiofosyl, Tiofosfamid, Triethylenethiophosphoramide SMILES C1CN1P(=S)(N2CC2)N3CC3

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-07-23)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT07616154 RECRUITING
Sickle Cell Disease
St. Jude Children's Research Hospital
2026-09 PHASE2
NCT05565105 NOT_YET_RECRUITING
Leukemia, Myeloid, Acute; Leukemia, Lymphocytic, Acute
Guenther Koehne
2026-06 PHASE2
NCT07759102 NOT_YET_RECRUITING
Recurrent Multiple Myeloma; Refractory Multiple Myeloma
University of California, Davis
2026-09-01 PHASE1
NCT07257419 RECRUITING
Relapsed Pediatric ALL; Hematopoietic Cell Transplantation; Hematologic Malignancy
St. Jude Children's Research Hospital
2026-10-03 PHASE1
NCT06013423 RECRUITING
Acute Leukemia of Ambiguous Lineage; Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Blastic Plasmacytoid Dendritic Cell Neoplasm; Hematopoietic and Lymphatic System Neoplasm; Mixed Phenotype Acute Leukemia; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Non-Hodgkin Lymphoma; Chronic Myeloid Leukemia, BCR-ABL1 Positive
Fred Hutchinson Cancer Center
2024-07-23 PHASE2
NCT02870907 ACTIVE_NOT_RECRUITING
Retinoblastoma
Institut Curie
2010-03-18 PHASE2

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.